BioXcel Therapeutics (NASDAQ:BTAI) Stock Quotes, Forecast and News Summary

Q: What sector and industry does BioXcel Therapeutics (BTAI) operate in?

BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile.

Open	$0.34
Close	$0.36
Volume / Avg.	764.87K / 853.13K
Day Range	$0.34 - $0.37
52 Wk Range	0.30 - 4.17
Market Cap	$18.76M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	1.95%
Days to Cover	1

Recent News

BioXcel Therapeutics' Approved Drug For Bipolar Disorders/Schizophrenia Shows No Evidence Of Worsening Or Withdrawal In Post-Marketing Study

BioXcel Therapeutics shares topline results from an Igalmi (dexmedetomidine) sublingual film study. The 180 mcg dose demonstrated favorable safety and efficacy in reducing agitation symptoms.

Vandana Singh

Why BioXcel Therapeutics Shares Are Rising Tuesday

BioXcel Therapeutics shares surge 25.1% as the company terminates its proposed public offering and shifts focus to upcoming FDA meeting and Phase 3 trial.

Nabaparna Bhattacharya

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Oct 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.9

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.34
Close	$0.36
Volume / Avg.	764.87K / 853.13K
Day Range	$0.34 - $0.37
52 Wk Range	0.30 - 4.17
Market Cap	$18.76M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	1.95%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BioXcel Therapeutics (BTAI) stock?

You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.

View our list of the best stock brokerages

Who are BioXcel Therapeutics (BTAI) competitors?

Other companies in BioXcel Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM), Imunon (NASDAQ:IMNN) and Evaxion Biotech (NASDAQ:EVAX).

What is the forecast, or price target, for BioXcel Therapeutics (BTAI) stock?

BioXcel Therapeutics has a consensus price target of $5.89.

What is the current price for BioXcel Therapeutics (BTAI)?

The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $0.378 last updated January 21, 2025 at 6:27 PM EST.

Does BioXcel Therapeutics (BTAI) pay a dividend?

There are no upcoming dividends for BioXcel Therapeutics.

When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?

BioXcel Therapeutics’s Q4 earnings are confirmed for Tuesday, March 11, 2025.

Is BioXcel Therapeutics (BTAI) going to split?

There is no upcoming split for BioXcel Therapeutics.

What sector and industry does BioXcel Therapeutics (BTAI) operate in?

BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

BioXcel Therapeutics

BioXcel Therapeutics (BTAI) Forecast

BioXcel Therapeutics (NASDAQ:BTAI) Stock Quotes, Forecast and News Summary

Recent News

Financials

Analyst Trends and Forecast

Analyst Rating and Forecast

Compare

FAQ

How do I buy BioXcel Therapeutics (BTAI) stock?

Who are BioXcel Therapeutics (BTAI) competitors?

What is the forecast, or price target, for BioXcel Therapeutics (BTAI) stock?

What is the current price for BioXcel Therapeutics (BTAI)?

Does BioXcel Therapeutics (BTAI) pay a dividend?

When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?

Is BioXcel Therapeutics (BTAI) going to split?

What sector and industry does BioXcel Therapeutics (BTAI) operate in?

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga